← Back to Search

Other

Topical Latanoprost/Minoxidil formulation for Hairy Birthmarks

Phase < 1
Recruiting
Led By Dan Cosgrove, M.D.
Research Sponsored by Aneira Pharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days

Summary

This trial tests a combination of two medications, latanoprost and minoxidil, to help people with thin or sparse eyebrows grow more hair. Latanoprost makes hair grow longer and thicker, while minoxidil wakes up hair follicles to produce more hair. Latanoprost, originally used to treat glaucoma, has been observed to induce hair growth and pigmentation, particularly in eyelashes.

Eligible Conditions
  • Hairy Birthmarks
  • Alopecia Areata

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Target Area Hair Count
Secondary study objectives
Change in Total Area Hair Darkness
Standardized Global Photographs
Other study objectives
Subject Self Assessment

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Topical Latanoprost/Minoxidil formulationExperimental Treatment1 Intervention
8 participants: Topical Latanoprost/Minoxidil formulation applied to both eyebrows once a day for 90 days
Group II: Control GroupPlacebo Group1 Intervention
4 participants: Vehicle applied to both eyebrows once a day for 90 days

Find a Location

Who is running the clinical trial?

Aneira Pharma, Inc.Lead Sponsor
1 Previous Clinical Trials
14 Total Patients Enrolled
Dan Cosgrove, M.D.Principal InvestigatorWellMax
~4 spots leftby Nov 2025